Alfen N.V. shares show a positive technical situation which suggests a continuation of the upward dynamic over the medium term. Investors have an opportunity to buy the stock and target the € 80.
Summary
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
Over the last twelve months, the sales forecast has been frequently revised upwards.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
The stock is in a well-established, long-term rising trend above the technical support level at 30.35 EUR
Weaknesses
With an enterprise value anticipated at 6.87 times the sales for the current fiscal year, the company turns out to be overvalued.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 127.88 times its estimated earnings per share for the ongoing year.
The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Disclaimer:
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.